Skip to main content
HighlightsHighlights Archive

Media Monitoring: 16 – 22 May

Proteins in blood could provide early cancer warning ‘by more than seven years’ Proteins in the blood could warn people of cancer more than seven years before it is diagnosed, according to research. Scientists at the University of Oxford studied blood samples from more than 44,000 people in the UK Biobank, including over 4,900 people who subsequently had a cancer…
Ben Kemp
May 22, 2024
HighlightsHighlights Archive

NHSE South East data provides evidence of virtual ward benefits

A large-scale evaluation of virtual wards in South East England has found the scheme saves money and prevents hospital admissions. NHS England South East region commissioned an independent evaluation from PPL to fill the critical large-scale evidence gap on virtual wards, offering actionable insights for healthcare providers, policymakers, and researchers. The evaluation analysed a total of 29 virtual ward pathways…
Ben Kemp
May 22, 2024
HighlightsHighlights Archive

Fleming Initiative boosted by £45m GSK investment

GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally. Global biopharma company GSK will become the first founding partner of the Fleming Initiative, an innovative and collaborative new approach led by Imperial College London and Imperial College Healthcare NHS Trust and to tackle antimicrobial resistance (AMR) around the world. A £45m pledge…
Ben Kemp
May 22, 2024
HighlightsHighlights Archive

Media Monitoring: 9 – 15 May

NHS launches tool to improve bowel cancer screening for people with sight loss Thousands of people with sight loss in England will find it easier to participate in life-saving bowel cancer screening thanks to a new specially designed NHS tool. People who are blind or partially sighted will be offered a specially designed tool to support them complete faecal immunochemical…
Ben Kemp
May 14, 2024
HighlightsHighlights Archive

Test-at-home blood tests for cancer patients approved

Regulatory approval has been granted for a novel device aimed at reducing the hospitalisation time of cancer patients. Named Liberty, this device empowers patients to conduct blood tests and share the results from the comfort of their homes, independently and without supervision. Advocates of Liberty highlight its potential to minimise the burden of frequent hospital visits on patients, while healthcare…
Ben Kemp
May 14, 2024
HighlightsHighlights Archive

NICE-recommended tumour profiling tests could prevent some breast cancer chemotherapy

NICE’s independent diagnostic advisory committee reviewed the evidence behind tumour profiling tests which are designed to provide information on the genetic makeup of breast cancer tumours. This information can be used to guide the treatment of women who have been through the menopause, and men, with oestrogen receptor (ER) or progesterone receptor (PR)-positive, human epidermal growth factor receptor 2 (HER2)-negative…
Ben Kemp
May 14, 2024
HighlightsHighlights Archive

Media Monitoring: 2 – 8 May

New blood test shows promise in early detection of ovarian cancer Epithelial ovarian cancer (EOC) accounts for the most significant number of deaths from female reproductive system cancers. A new paper published in the British Journal of Cancer explores the potential utility of glycoproteins as biomarkers of EOC. In the future, these types of models might allow the diagnosis of…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

New screening trial to save thousands of men’s lives from prostate cancer

Thousands more men could be saved every year as a new screening trial aims to double the efficacy of prostate cancer screening. The £42m trial called TRANSFORM aims to find the best way to screen men for prostate cancer and is co-funded by Prostate Cancer UK and NIHR. The Government is investing £16m for the trial through NIHR. Movember is providing £1.5m funding, and…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

ONS says UK R&D may be worth far more than currently estimated

Early findings from a revamped Office for National Statistics survey published suggest that the value of research and development undertaken in Britain each year could be more than 20% higher than estimates currently show. According to the redeveloped Business Enterprise Research and Development Survey, R&D expenditure in 2022 amounted to £53 billion pounds, compared with an existing estimate of £43.4 billion pounds…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

Media Monitoring: April 25 – May 1

Virtual wards: We are in danger of being eclipsed by our European neighbours Great progress has been made in extending virtual wards across the NHS in England. It is leading the way on virtual ward provision. However, there is a risk of being eclipsed by other European countries on the use of remote monitoring for wider health care. We can…
Ben Kemp
April 29, 2024